Medicine & Life Sciences
4-1BB Ligand
23%
Actinobacillus pleuropneumoniae
42%
Adenoviridae
54%
Adenovirus Vaccines
45%
AIDS Vaccines
41%
Antibodies
20%
Antibody Formation
42%
Antigens
72%
Cancer Vaccines
16%
Cell Movement
16%
Cellular Immunity
17%
chondroitin sulfate glycosaminoglycan
22%
Chondroitin Sulfates
19%
Epitopes
19%
Herpesviridae Infections
17%
HIV-1
15%
Human Adenoviruses
17%
Human Herpesvirus 4
15%
Immunization
46%
Infections
15%
invariant chain
35%
Macaca
23%
Malaria
27%
Membranes
16%
Neoplasms
18%
Plasmodium falciparum
18%
Primates
19%
Rhadinovirus
21%
Serogroup
28%
T-Lymphocytes
93%
Tail
25%
Vaccination
59%
Vaccines
100%
Viral Vaccines
19%
Viremia
15%
Virion
25%
Virus-Like Particle Vaccines
16%
Viruses
41%
Agriculture & Biology
Actinobacillus pleuropneumoniae
37%
Adenoviridae
51%
antibodies
15%
antigens
50%
cancer vaccines
24%
epitopes
19%
Human immunodeficiency virus 1
16%
immunization
17%
immunogenicity
20%
infection
19%
Macaca fascicularis
15%
Mastadenovirus
19%
mice
19%
Murid gammaherpesvirus 4
25%
neoplasm progression
20%
serotypes
26%
T-lymphocytes
35%
tail
22%
vaccination
15%
vaccines
60%
virus-like particles
34%
viruses
15%